PXD015748 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy |
Description | Identification of physiologically relevant peptide vaccine targets calls for the direct analysis of the entirety of naturally presented human leukocyte antigen (HLA) ligands, termed the HLA ligandome. In this study, we implemented this direct approach using immunoprecipitation and mass spectrometry to define acute myeloid leukemia (AML)-associated peptide vaccine targets. Mapping the HLA class I ligandomes of 15 AML patients and 35 healthy controls, more than 25 000 different naturally presented HLA ligands were identified. Target prioritization based on AML exclusivity and high presentation frequency in the AML cohort identified a panel of 132 LiTAAs (ligandome-derived tumor-associated antigens), and 341 corresponding HLA ligands (LiTAPs (ligandome-derived tumor-associated peptides)) represented subset independently in >20% of AML patients. Functional characterization of LiTAPs by interferon-γ ELISPOT (Enzyme-Linked ImmunoSpot) and intracellular cytokine staining confirmed AML-specific CD8+ T-cell recognition. Of note, our platform identified HLA ligands representing several established AML-associated antigens (e.g. NPM1, MAGED1, PRTN3, MPO, WT1), but found 80% of them to be also represented in healthy control samples. Mapping of HLA class II ligandomes provided additional CD4+ T-cell epitopes and potentially synergistic embedded HLA ligands, allowing for complementation of a multipeptide vaccine for the immunotherapy of AML. |
HostingRepository | PRIDE |
AnnounceDate | 2024-10-22 |
AnnouncementXML | Submission_2024-10-22_04:05:42.483.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Annika Nelde |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | LTQ Orbitrap |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2019-10-08 23:20:28 | ID requested | |
1 | 2019-10-14 02:23:02 | announced | |
2 | 2019-10-16 07:51:50 | announced | 2019-10-16: Updated publication reference for PubMed record(s): 25092142. |
3 | 2019-11-27 06:27:46 | announced | 2019-11-27: Updated project metadata. |
⏵ 4 | 2024-10-22 04:05:44 | announced | 2024-10-22: Updated project metadata. |
Publication List
10.1038/leu.2014.233; |
Berlin C, Kowalewski DJ, Schuster H, Mirza N, Walz S, Handel M, Schmid-Horch B, Salih HR, Kanz L, Rammensee HG, Stevanovi, ć S, Stickel JS, Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy. Leukemia, 29(3):647-59(2015) [pubmed] |
Keyword List
curator keyword: Biomedical |
submitter keyword: acute myeloid leukemia,LC-MSMS |
Contact List
Juliane S. Walz (neé Stickel) |
contact affiliation | Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany |
contact email | juliane.walz@med.uni-tuebingen.de |
lab head | |
Annika Nelde |
contact affiliation | Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany |
contact email | annika.nelde@uni-tuebingen.de |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/10/PXD015748 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD015748
- Label: PRIDE project
- Name: Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy